Detalles de la búsqueda
1.
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients.
Breast Cancer Res Treat
; 184(2): 311-324, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32852708
2.
ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro.
BMC Cancer
; 18(1): 1273, 2018 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30567518
3.
Genetic risk factors for ovarian cancer and their role for endometriosis risk.
Gynecol Oncol
; 145(1): 142-147, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28214017
4.
Genetic variants in VEGF pathway genes in neoadjuvant breast cancer patients receiving bevacizumab: Results from the randomized phase III GeparQuinto study.
Int J Cancer
; 137(12): 2981-8, 2015 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26100253
5.
Quality-Assured Analysis of PIK3CA Mutations in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Tissue: A Story About the Need for Proficiency Testing for High-Quality Molecular Biomarker Reporting in Precision Medicine.
J Mol Diagn
; 2024 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697471
6.
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy.
Cancers (Basel)
; 15(19)2023 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37835372
7.
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer - A single-arm phase II trial (NeoImmunoboost, AGO-B-041).
Eur J Cancer
; 184: 1-9, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871424
8.
Prevalence of SARS-CoV-2 in Pregnant Women Assessed by RT-PCR in Franconia, Germany: First Results of the SCENARIO Study (SARS-CoV-2 prEvalence in pregNAncy and at biRth In FrancOnia).
Geburtshilfe Frauenheilkd
; 82(2): 226-234, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35169390
9.
Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis.
J Clin Oncol
; 39(15): 1619-1630, 2021 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33780288
10.
HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer.
Geburtshilfe Frauenheilkd
; 80(11): 1123-1133, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33173240
11.
Correction: SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection.
Oncotarget
; 11(30): 2958, 2020 Jul 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32774775
12.
SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection.
Oncotarget
; 10(60): 6494-6508, 2019 Nov 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31741713
13.
Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer.
Fertil Steril
; 112(4): 731-739.e1, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31371054
14.
Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer Patients.
Front Pharmacol
; 9: 158, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29593529
15.
MicroRNA in diagnosis and therapy monitoring of early-stage triple-negative breast cancer.
Sci Rep
; 8(1): 11584, 2018 08 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30072748
16.
TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes.
Breast Care (Basel)
; 13(1): 8-14, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29950961
17.
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study.
J Clin Oncol
; 36(22): 2281-2287, 2018 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29791287
18.
Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.
Cancer Med
; 7(5): 1978-1987, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29608257
19.
Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods.
Geburtshilfe Frauenheilkd
; 77(6): 667-678, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28757654
20.
Implementation and Feasibility of Electronic Patient-Reported Outcome (ePRO) Data Entry in the PRAEGNANT Real-Time Advanced and Metastatic Breast Cancer Registry.
Geburtshilfe Frauenheilkd
; 77(8): 870-878, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28845051